Hopkins researchers uncover key to antidepressant response

Discovery shows how therapies activate stem cells in the brain

2013-02-07

(Press-News.org) Through a series of investigations in mice and humans, Johns Hopkins researchers have identified a protein that appears to be the target of both antidepressant drugs and electroconvulsive therapy. Results of their experiments explain how these therapies likely work to relieve depression by stimulating stem cells in the brain to grow and mature. In addition, the researchers say, these experiments raise the possibility of predicting individual people's response to depression therapy, and fine-tuning treatment accordingly. Reports on separate aspects of the research were published in December on the Molecular Psychiatry website, and will also appear in the Feb. 7 issue of Cell Stem Cell.

"Previous studies have shown that antidepressants and electroconvulsive therapy both activate neural stem cells in the adult brain to divide and form new neurons," says Hongjun Song, Ph.D., a professor of neurology and director of the Stem Cell Program at the Johns Hopkins University School of Medicine's Institute for Cell Engineering. "What were missing were the specific molecules linking antidepressant treatment and stem cell activation."

To make that link, Song's team and its collaborators assembled a body of evidence from different types of experiments. In one, they compared gene activity in the brains of mice that had and had not been treated with electroconvulsive therapy, looking specifically at genes with protein products that are known to regulate neural stem cells. The comparison turned up differences in the activity of one inhibitor gene for a chemical chain reaction that had been previously implicated in stimulating neural stem cells. Specifically, the therapy reduced the amount of protein the inhibitor gene, sFRP3, produced, which would in turn have given the growth-stimulating chain reaction freer rein.

To learn more about sFRP3's effects, the team next compared normal mice with mice that had been engineered to lack the sFRP3 protein. They found that the modified mice behaved like normal mice on antidepressants; moreover, giving antidepressants to the modified mice did not further change their behavior. This strongly suggested that antidepressants work by blocking sFRP3; without sFRP3, the modified mice had nothing to block.

In order to tie their mouse work to what happens in the human brain, the researchers next analyzed genetic information from 541 depression patients and tracked their response to a course of antidepressant drugs. The team found three common variations in the human version of sFRP3 that were linked to a better response to therapy. Wondering what these variations actually did, the researchers searched a database that correlates gene sequences to gene activity in the human brain. All three variations caused less gene activity, they found, meaning that there likely would have been less inhibitor.

Song notes that sFRP3 is also regulated by other conditions, including exercise. "This gene's activity is very sensitive to the amount of activity in the brain, so sFRP3 seems to be a gatekeeper that links activity to new neuron growth," he says. The finding has two major near-term implications, he says: It could lead to genetic tests that enable doctors to predict a patient's response to antidepressants, and it provides a target for potential new therapies for the disease.

INFORMATION:

The studies were supported by the National Institute of Mental Health (grant numbers MH090115 and MH087874), the National Institute of Neurological Disorders and Stroke (grant numbers NS048271, NS047344 and NS080913), the National Institute of Child Health and Human Development (grant number HD069184), the National Institute of Environmental Health Sciences (grant number ES021957), the Brain & Behavior Research Foundation, the Maryland Stem Cell Research Fund, the International Mental Health Research Organization and the Max Planck Society.

Other authors on the Cell Stem Cell article are Mi-Hyeon Jang, Michael A. Bonaguidi, Yasuji Kitabatake, Jiaqi Sun, Juan Song, Eunchai Kang, Heechul Jun, Chun Zhong, Yijing Su, Junjie U. Guo, Marie Xun Wang, Kurt A. Sailor, Ju-Young Kim, Yuan Gao, Kimberly M. Christian and Guo-li Ming of the Johns Hopkins University School of Medicine. Other authors on the Molecular Psychiatry article are Mi-Hyeon Jang, Yasuji Kitabatake, Eunchai Kang, Heechul Jun, Mikhail V. Pletnikov, Kimberly M. Christian and Guo-li Ming of the Johns Hopkins University School of Medicine; René Hen of Columbia University; and Susanne Lucae and Elizabeth B. Binder of the Max Planck Institute of Psychiatry.

Link to Molecular Psychiatry paper: http://www.nature.com/mp/journal/vaop/ncurrent/full/mp2012158a.html

Related materials:

Video: Hongjun Song on using stem cells in the brain to study mental disorders: http://www.hopkinsmedicine.org/institute_cell_engineering/_includes/videos/Transcriptions/Song_txn.html

Brain's Stem Cells 'Eavesdrop' to Find Out When to Act: http://www.hopkinsmedicine.org/news/media/releases/brains_stem_cells_eavesdrop_to_find_out_when_to_act

Growth of New Brain Cells Requires 'Epigenetic' Switch: http://www.hopkinsmedicine.org/news/media/releases/growth_of_new_brain_cells_requires_epigenetic_switch

Johns Hopkins Researcher Shares Society for Neuroscience Young Investigator Award: http://www.hopkinsmedicine.org/news/media/releases/Johns_Hopkins_Researcher_Shares_Society_For_Neuroscience_Young_Investigator_Award

Johns Hopkins Scientists Discover 'Fickle' DNA Changes in Brain: http://www.hopkinsmedicine.org/news/media/releases/johns_hopkins_scientists_discover_fickle_dna_changes_in_brain

Normal Role for Schizophrenia Risk Gene Identified: http://www.hopkinsmedicine.org/news/media/releases/Normal_Role_for_Schizophrenia_Risk_Gene_Identified

Love in the Laboratory: http://www.hopkinsmedicine.org/dome/0512/holiday4.cfm

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Treatment with clot-busting drug yields better results after stroke than supportive therapy alone

2013-02-07

In an update to previous research, Johns Hopkins neurologists say minimally invasive delivery of the drug tPA directly into potentially lethal blood clots in the brain helped more patients function independently a year after suffering an intracerebral hemorrhage (ICH), a deadly and debilitating form of stroke. Rates of functional recovery with the active tPA treatment far surpassed those achieved with standard "supportive" therapy that essentially gives clots a chance to shrink on their own. In the current Johns Hopkins-led study, ICH patients who randomly received the ...

Clot-retrieval devices failed to improve stroke-related disability

2013-02-07

A stroke survivor's chances of living independently after 90 days are not improved by the use of devices inserted into the artery to dissolve or remove a stroke-causing clot shortly after the onset of symptoms, according to a randomized controlled trial involving 656 patients. The study, funded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, compared the intra-arterial device-based approach plus the current standard of intravenous (IV) tissue plasminogen activator (t-PA), a clot-busting drug with IV t-PA ...

In the brain, broken down 'motors' cause anxiety

2013-02-07

VIDEO: This video (S3 in the paper) shows the transport defect of the serotonin receptor in a KIF13A knock out neuron compared with a wild type neuron. Click here for more information. When motors break down, getting where you want to go becomes a struggle. Problems arise in much the same way for critical brain receptors when the molecular motors they depend on fail to operate. Now, researchers reporting in Cell Reports, a Cell Press publication, on February 7, have shown ...

Salmon may use magnetic field as a navigational aid

2013-02-07

CORVALLIS, Ore. – The mystery of how salmon navigate across thousands of miles of open ocean to locate their river of origin before journeying upstream to spawn has intrigued biologists for decades, and now a new study may offer a clue to the fishes' homing strategy. In the study, scientists examined 56 years of fisheries data documenting the return of sockeye salmon to the Fraser River in British Columbia – and the route they chose around Vancouver Island showed a correlation with changes in the intensity of the geomagnetic field. Results of the study, which was supported ...

Immune systems of healthy adults 'remember' germs to which they've never been exposed

2013-02-07

STANFORD, Calif. — It's established dogma that the immune system develops a "memory" of a microbial pathogen, with a correspondingly enhanced readiness to combat that microbe, only upon exposure to it — or to its components though a vaccine. But a discovery by Stanford University School of Medicine researchers casts doubt on that dogma. In a path-breaking study to be published online Feb. 7 in Immunity, the investigators found that over the course of our lives, CD4 cells — key players circulating in blood and lymph whose ability to kick-start the immune response to viral, ...

Cells forged from human skin show promise in treating MS, myelin disorders

2013-02-07

A study out today in the journal Cell Stem Cell shows that human brain cells created by reprogramming skin cells are highly effective in treating myelin disorders, a family of diseases that includes multiple sclerosis and rare childhood disorders called pediatric leukodystrophies. The study is the first successful attempt to employ human induced pluripotent stem cells (hiPSC) to produce a population of cells that are critical to neural signaling in the brain. In this instance, the researchers utilized cells crafted from human skin and transplanted them into animal models ...

Zinc helps against infection by tapping brakes in immune response

2013-02-07

COLUMBUS, Ohio – New research suggests that zinc helps control infections by gently tapping the brakes on the immune response in a way that prevents out-of-control inflammation that can be damaging and even deadly. Scientists determined in human cell culture and animal studies that a protein lures zinc into key cells that are first-responders against infection. The zinc then interacts with a process that is vital to the fight against infection and by doing so helps balance the immune response. This study revealed for the first time that zinc homes in on this pathway ...

Study shows disease spread in ladybirds with sexually transmitted disease

2013-02-07

A study at the University of Liverpool into the spread of sexually transmitted infection in ladybirds has shown that disease risk to large populations cannot be predicted without a full understanding of the disease dynamics at small geographical scale. Scientists investigated a virulent form of infection in the central and northern European populations of the two-spot ladybird to understand the conditions that favoured disease spread. Researchers found that disease burden in two locations of the same habitat – the lime tree - were very different, despite being within ...

New technology may help doctors monitor concussions, aging, and neurological function

2013-02-07

Boston, MA, Feb. 7, 2013 – Doctors routinely track their patients' hand-eye coordination to monitor any neuromuscular deficits, particularly as patients age or when they are injured -- but the tests they have been using to track this kind of information may be subjective and qualitative. Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University, the Beth Israel Deaconess Medical Center, and Hebrew SeniorLife, Boston (BIDMC), recently completed the first clinical study of a new rapid neuroassessment device they developed to quantitatively ...

Unique peptide could treat cancers, neurological disorders, and infectious diseases

2013-02-07

DALLAS – Feb. 7, 2013 – UT Southwestern Medical Center scientists have synthesized a peptide that shows potential for pharmaceutical development into agents for treating infections, neurodegenerative disorders, and cancer through an ability to induce a cell-recycling process called autophagy. Autophagy is a fundamental recycling process in which intracellular enzymes digest unneeded and broken parts of the cell into their individual building blocks, which are then reassembled into new parts. The role of autophagy is crucial both in keeping cells healthy and in enabling ...

Hopkins researchers uncover key to antidepressant response

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: